Richard Lee

Richard Lee is a Professor of Cardiovascular Medicine at Harvard University, where he leads a prominent research laboratory dedicated to advancing cardiac therapeutics and regenerative approaches. He earned his medical degree and completed advanced training in cardiology and molecular biology before establishing his independent research program. Dr. Lee's research focuses on cardiac valve diseases and treatments, tissue engineering and regenerative medicine, and the pathophysiology of congenital heart defects. His work integrates molecular biology, bioengineering, and clinical insights to develop novel therapeutic strategies for structural and functional heart disorders. A significant portion of his research examines arrhythmogenesis in transplanted human cardiomyocytes using flexible nanoelectronics, as well as the role of growth differentiation factors like GDF11/8 in predicting cardiovascular outcomes. With an h-index of 118 and nearly 1,000 publications, Dr. Lee has made substantial contributions to understanding cardiac regeneration and repair mechanisms. His laboratory actively explores how engineered tissues and biomaterials can restore cardiac function, and his recent investigations extend to interdisciplinary areas including physiological predictability in team performance. Dr. Lee's research is characterized by its translational emphasis, aiming to bridge foundational discoveries in cardiac biology with clinical applications to improve patient care in cardiovascular medicine. Their recent contributions to the field are exemplified by influential works such as "Redistribution of villin to proximal tubule basolateral membranes after ischemia and reperfusion", and "Robot-Assisted Laparoscopic Ileal Bladder Augmentation: Defining Techniques and Potential Pitfalls".